Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Cytovance Biologics, Inc. announces that it has teamed up with NeuroFx to develop and manufacture stem cell derived, cell-free therapy for neurological conditions.
read more
A federal appeals court has ruled that Novartis can begin selling its lower-cost copy of an Amgen Inc. drug in September.
read more
PAREXEL International Corporation has launched the next generation of its Perceptive MyTrials® platform with advanced analytics capabilities.
read more
Amgen on Tuesday received European approval for its first-of-a-kind cholesterol drug that lowers levels of the artery-clogging substance more than older drugs that have been prescribed for decades.
read more
More than 1 in 5 sexually active teen girls have used the morning-after pill — a dramatic increase that likely reflects that it's easier now for teens to buy the emergency contraceptive.
read more
Bristol-Myers said Tuesday that federal regulators will help speed up development for one of its experimental HIV drugs.
read more
Pfizer has expanded its research on vaccines to eventually safeguard people from cradle to grave, from shots for pregnant women to protect their babies from the moment of birth to vaccines for senior citizens with waning immune systems
read more
BioPlan Associates’ 12th Annual Report and Survey of BioManufacturing, the industry's definitive, quantitative analysis has been released, including 12 years of biopharma trends analysis and review of current opportunities.
read more
Vetter today has announced the release of Vetter-Ject, a novel closure system for prefilled syringes. By this closure part a baked-in siliconization of an integrated needle syringe can be realized. That allows the use in highly-sensitive compounds ...
read more
2015 Program to Discuss ‘Where Product Integrity Meets Value: Balancing Compliance, Risks and Costs’
Pharmaceutical Outsourcing is proud to announce it’s partnership with IQPC’s 13th Annual Cold Chain GDP & Temperature Management Logistics Global ...
read more
Nanotherapeutics has received two new Task Orders from The United States Department of Health and Human Services, Biomedical Advanced Research and Development Authority Fill-Finish Manufacturing Network’s Pilot Production program, for the Center for...
read more
Walgreens Boots Alliance Inc. has named Stefano Pessina CEO, making permanent a role the executive has filled since the largest drugstore chains in the United States and Great Britain combined to create one of the world's biggest pharmaceutical ...
read more
Recipharm Venture Fund AB has together with Östersjöstiftelsen and Praktikerinvest made a joint investment of SEK 28 million in Pharmanest AB
read more
EAG, Inc. (Evans Analytical Group), a fully integrated, independent laboratory network, providing analytical and testing services to a broad base of customers in the agrochemical and pharmaceutical industries, announced that it has acquired ...
read more
Accelovance, a global contract research organization has announced the completion of enrollment and delivery of the final locked database to Heron Therapeutics for the Phase 3 trial of its 5-HT3 receptor antagonist product candidate SUSTOL®.
read more